比卡胺 的英文怎麼說

中文拼音 [bǐkǎàn]
比卡胺 英文
bicalutamide
  • 比 : Ⅰ動詞1 （比較; 較量高下、 長短、距離、好壞等） compare; compete; contrast; match; emulate 2 （比...
  • 胺 : 名詞[化學] amine （氨 nh3 分子中部分或全部氫原子被烴基取代而成的有機化合物）
  • 比卡 : bica
  1. Conclusions the frequency of clinically important valve regurgitation was significantly increased in patients taking pergolide or cabergoline, but not in patients taking non ? ergot - derived dopamine agonists, as compared with control subjects

    結論：與對照組相比，服用培高利特或者卡麥角林的患者臨床上發生重要瓣膜返流的頻率顯著增加，但服用非麥角?生的多巴胺受體激動劑的患者瓣膜返流的發生率卻未增加。
  2. Results clinically important regurgitation ( moderate to severe, grade 3 to 4 ) in any valve was found with significantly greater frequency in patients taking pergolide ( 23. 4 % ) or cabergoline ( 28. 6 % ) but not in patients taking non ? ergot - derived dopamine agonists ( 0 % ), as compared with control subjects ( 5. 6 % )

    結果：與對照組相比（ 5 . 6 % ） ，服用培高利特（ 23 . 4 % ）或者卡麥角林的患者（ 28 . 6 % ） ，臨床上發生重要的任何瓣膜的返流（中到重度， 3級到4級）的頻率顯著升高，而服用非麥角?生的多巴胺受體激動劑的患者（ 0 % ）瓣膜返流的發生率卻未增加。
  3. The residual solvents in bicalutamide substance were determined by gc

    摘要採用氣相色譜法測定比卡魯胺原料藥中有機溶劑殘留量。
  4. Ffns 110 mcg once - daily showed numerical reductions in the primary endpoint, which were not significant when compared with placebo

    氟替卡松安特酰胺鼻腔噴霧每日110mcg在治療初期評分減少數與安慰劑比較無顯著差異性。
  5. Oerall, after four weeks ' treatment, for the primary endpoint, study participants were ealuated for reductions in total nasal symptom scores for ffns compared with placebo

    經4周的治療后，對主要時間點，全部參與研究者評價其全鼻癥狀評分，並且氟替卡松安特酰胺鼻腔噴霧組評分與安慰劑組相比較減少。
  6. Thionamides class of anti - thyroid drugs ( such as carbimazole, methimazole, and propylthiouracil ) that inhibit thyroid hormone synthesis by interfering with organification

    硫酰胺類抗甲狀腺藥物的種類（如卡比馬唑、甲巰咪唑和丙基硫氧嘧啶） ，此類藥物通過干擾有機化抑制甲狀腺激素的合成。
分享友人
分享到 Line

分享到臉書